Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Echo-CT-ProtecT-2-D: Effects of an Integrated Multifactorial Cardiometabolic Intervention and Identification of Unrecognized HFpEF in Patients With Type 2 Diabetes and Established Cardiovascular Disease

NCT07878325 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

NCT NCT07878325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07878325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Echo-CT-ProtecT-2-D: Effects of an Integrated Multifactorial Cardiometabolic Intervention and Identification of Unrecognized HFpEF in Patients With Type 2 Diabetes and Established Cardiovascular Disease
Lead sponsor
Odense University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
October 20, 2026
Completion date
December 1, 2027
Enrollment
375 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiometabolic diseases, cardiovascular disease, diabetes and heart failure, diabetes complication, diabetes type 2, heart failure with preserved ejection fraction (hfpef